Medicare Enrolled

Dr. Tejinder Kalra, MD

Internal Medicine · Cheektowaga, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2671 HARLEM RD, Cheektowaga, NY 14225
7168929678
Registered in NPPES since 2006
NPI: 1629015011 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kalra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kalra

Dr. Tejinder Kalra is an internal medicine specialist in Cheektowaga, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kalra performed 688 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Kalra received a total of $6,189 from 30 pharmaceutical and/or device companies across 319 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kalra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 43% volume in NY $6,189 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
688
Medicare services
Top 43% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
208 $57 $106
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
126 $84 $155
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
104 $55 $111
Assessment of emotional or behavioral problems
An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns.
76 $3 $8
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
65 $50 $200
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
29 $191 $320
Quadrivalent influenza vaccine, cell culture-derived
A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods.
28 $32 $75
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
28 $30 $32
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
24 $131 $212
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,189
Total received (2018-2024)
Avg $884/year across 7 years
Top 14% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
319
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$614
2023
$886
2022
$614
2021
$1,184
2020
$426
2019
$1,289
2018
$1,176

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$175
Exact Sciences Corporation
$106
Novo Nordisk Inc
$82
GlaxoSmithKline, LLC.
$65
Phathom Pharmaceuticals, Inc.
$43
PFIZER INC.
$42
E.R. Squibb & Sons, L.L.C.
$40
Amgen Inc.
$33
Esperion Therapeutics, Inc.
$28
Top 3 companies account for 59.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,048
GlaxoSmithKline, LLC.
$791
PFIZER INC.
$706
Novo Nordisk Inc
$459
Janssen Pharmaceuticals, Inc
$455
E.R. Squibb & Sons, L.L.C.
$384
Astellas Pharma US Inc
$304
ABBVIE INC.
$222
Horizon Therapeutics plc
$213
Exact Sciences Corporation
$180
Amarin Pharma Inc.
$148
Lilly USA, LLC
$144
Boehringer Ingelheim Pharmaceuticals, Inc.
$140
Amgen Inc.
$140
Merck Sharp & Dohme Corporation
$112
Mallinckrodt Enterprises LLC
$109
Novartis Pharmaceuticals Corporation
$105
Kowa Pharmaceuticals America, Inc.
$76
Esperion Therapeutics, Inc.
$76
Medtronic USA, Inc.
$64
Sumitomo Pharma America, Inc.
$57
Bayer HealthCare Pharmaceuticals Inc.
$55
Phathom Pharmaceuticals, Inc.
$43
Melinta Therapeutics, Inc.
$34
Allergan Inc.
$34
Abbott Laboratories
$23
Shield Therapeutics Inc
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Circassia Pharmaceuticals Inc
$14
Covidien LP
$12
Top 3 companies account for 41.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · CHANTIX · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · GEMTESA · INTERSTIM · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · Orbactiv · Otezla · Ozempic · PNEUMOVAX 23 · PillCam · QULIPTA · RYBELSUS · Rybelsus · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · TOVIAZ · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Tresiba · UBRELVY · VESICARE · VIAGRA · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an internal medicine specialist in Cheektowaga?
Compare internal medicine physicians in the Cheektowaga area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians in nearby ZIP areas
531
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
3.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kalra is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kalra experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Kalra performed 208 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kalra receive payments from pharmaceutical companies?
Yes. Dr. Kalra received a total of $6,189 from 30 companies across 319 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalra's costs compare to other internal medicine physicians in Cheektowaga?
Dr. Kalra's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →